Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1. (Q46025973)
Jump to navigation
Jump to search
scientific article published on 4 May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1. |
scientific article published on 4 May 2009 |
Statements
1 reference
Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1. (English)
1 reference
1 reference
Bee K Tan
1 reference
Raghu Adya
1 reference
Jing Chen
1 reference
Syed Farhatullah
1 reference
Dennis Heutling
1 reference
Hendrik Lehnert
1 reference
Harpal S Randeva
1 reference
4 May 2009
1 reference
1 reference
83
1 reference
3
1 reference
566-574
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference